Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More26 - 30 of 154 results
In this article by Contract Pharma, Thierry Van Nieuwenhove, the CEO of Quotient Sciences discusses how the CDMO is positioning itself to stay ahead of the curve and what are the most significant trends in the CDMO industry. Thierr...
Learn moreIn this article by 247 BioPharma, Thierry Van Nieuwenhove, the CEO of Quotient Sciences discusses the primary company goals and what steps the Quotient Sciences is taking to meet evolving regulatory requirements.In addition, Thierry talks a...
Learn more
Dr. Lewis talked with PharmTech Europe about the chemistry, manufacturing, and control (CMC) challenges encountered during the development of glucagon-like peptide 1 (GLP-1) and oral peptides.
Learn more
In this article by Pharmaceutical Manufacturer, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses how the company is innovating to meet the growing demand for personalized medicine through AI, partnerships and meeting sustainabil...
Learn more
In this article by Outsourcing Pharma,  Quotient Sciences CEO Thierry Van Nieuwenhove shared insights on how the company is adapting to new FDA regulations.Thierry also discusses how the company is expanding its Translational Pharm...
Learn more
